Ipidacrine

CAS No. 62732-44-9

Ipidacrine( NIK‐247 )

Catalog No. M21155 CAS No. 62732-44-9

Ipidacrine (NIK‐247) is an Antidementia Agent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
25MG 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ipidacrine
  • Note
    Research use only, not for human use.
  • Brief Description
    Ipidacrine (NIK‐247) is an Antidementia Agent.
  • Description
    Ipidacrine (NIK‐247) is an Antidementia Agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NIK‐247
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    62732-44-9
  • Formula Weight
    188.27
  • Molecular Formula
    C12H16N2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Nc1c2c(nc3c1CCC3)CCCC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Onodera K Kojima J Wachi M . Ipidacrine (NIK-247) a novel antidementia rapidly enters the brain and improves scopolamine-induced amnesia in rats during the Morris water maze task[J]. Japanese Journal of Psychopharmacology 1998 18(2):33-37.
molnova catalog
related products
  • 8-Oxoepiberberine

    8-Oxoepiberberine is an alkaloid metabolite in the plasma after oral administration of Zuojin formula, a traditional chinese medicine used to treat gastrointestinal disease.

  • Oxindole

    Oxindole is an aromatic heterocyclic building block.?2-indolinone derivatives have become lead compounds in the research of kinase inhibitors.Oxindole structure has been used in receptor tyrosine kinases (RTKs) inhibitors such as SU4984 and intedanib, the RTK family represents an important therapeutic target for anti-cancer drug development.

  • Racotumomab

    Racotumomab (Anti-Human NGcGM3 Recombinant Antibody) is a mouse γ-type anti-recombinant antibody that specifically induces an antibody response against Neu-glycolyl GM3 ganglioside (NeuGcGM3), overexpressed in various solid tumors.